CardiAMP Cell Therapy System
Phase 3- Indications
- Heart failure, Chronic myocardial ischemia
Company intelligence / Profile preview
Sonitus Medical
San Mateo, California, United Statessonitusmedical.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The SoundBite Hearing System received FDA clearance for treatment of single sided deafness and conductive hearing loss, and CE Mark certification in the European Union for single sided deafness, conductive hearing loss, and mixed hearing loss[1][3].
- Therapeutic areas
- OtherNeurology
- Modalities
- Bone conduction hearing devices
- Industry
- Assistive Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
BHM (recent strategic cooperation announced in April 2025)[3]
Beyond the preview
Go deeper on Sonitus Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sonitus Medical.